ANDA 74812, held by Esi Lederle. Potassium Chloride.
As of Nov 15, 2026, ANDA 74812 (Potassium Chloride), held by Esi Lederle, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 11, 1999 | Original application | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Potassium Chloride20MEQ ยท tablet; oral | Potassium Chloride | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
